Extended trial tests seizure Drug's safety for rare genetic disorder
Disease control
Terminated
This study aimed to evaluate the long-term safety and effectiveness of an add-on medication called ganaxolone for controlling seizures in children and adults with Tuberous Sclerosis Complex (TSC). It was an extension study for 117 participants who had completed earlier ganaxolone…
Phase: PHASE3 • Sponsor: Marinus Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC